Co-receptor usage and prediction of v3 genotyping algorithms in hiv-1 subtype b' from paid blood donors experienced anti-retroviral therapy in chinese central province

Virology Journal

Volumn 7, Issue , 2010, Pages

  Qu, Shuiling ^a   Ma, Liying ^a   Yuan, Lin ^a   Xu, Wesi ^a   Hong, Kunxue ^a   Xing, Hui ^a   Huang, Yang ^a   Yu, Xiaoling ^a   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DIDANOSINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE; GLYCOPROTEIN GP 120; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; VIRUS RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD DONOR; CHINA; FEMALE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; VIRUS ISOLATION; VIRUS STRAIN; ALGORITHM; CELL LINE; CLUSTER ANALYSIS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNET; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYLOGENY; PHYSIOLOGY; VIROLOGY; VIRUS ATTACHMENT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ALGORITHMS; BLOOD DONORS; CELL LINE; CHINA; CLUSTER ANALYSIS; FEMALE; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INTERNET; MALE; MIDDLE AGED; PHYLOGENY; RECEPTORS, HIV; VIROLOGY; VIRUS ATTACHMENT;

EID: 77958077685     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-280     Document Type: Article

References (23)

1. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals. ZL Brumme J Goodrich HB Mayer CJ Brumme BM Henrick B Wynhoven JJ Asselin PK Cheung RS Hogg JS Montaner PR Harrigan, J Infect Dis 2005 192 3 466 74 10.1086/431519 15995960
2. Change in coreceptor use correlates with disease progression in HIV-1 - infected individuals. RI Connor KE Sheridan D Ceradini S Choe NR Landau, J Exp Med 1997 185 4 621 8 10.1084/jem.185.4.621 9034141
3. R5 to X4 coreceptor switch of human immunodeficiency virus type 1 B' and B'/C recombinant subtype isolates in China. YF Guo LY Ma L Yuan SH Wang JP Sun WS Xu JQ Xu H Xing KX Ong XY Zhang YH Ruan YX Zhang YM Shao, Chin Med J (Engl) 2007 120 6 522 5 17439749
4. HIV-1 subtype C in vitro growth and coreceptor utilization. T Ndung'u E Sepako MF McLane F Chand K Bedi S Gaseitsiwe F Doualla-Bell T Peter I Thior SM Moyo PB Gilbert VA Novitsky M Essex, Virology 2006 347 2 247 60 10.1016/j.virol.2005.11.047 16406460
5. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. W Huang SH Eshleman J Toma S Fransen E Stawiski EE Paxinos JM Whitcomb AM Young D Donnell F Mmiro P Musoke LA Guay JB Jackson NT Parkin CJ Petropoulos, J Virol 2007 81 15 7885 93 10.1128/JVI.00218-07 17507467
6. Stable coreceptor usage of HIV in patients with ongoing treatment failure on HAART. C Lehmann M Daumer I Boussaad T Sing N Beerenwinkel T Lengauer N Schmeisser C Wyen G Fatkenheuer R Kaiser, J Clin Virol 2006 37 4 300 4 10.1016/j.jcv.2006.08.008 17005445
7. Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy. S Philpott B Weiser K Anastos CM Kitchen E Robison WA Meyer HS Sacks U Mathur-Wagh C Brunner H Burger, J Clin Invest 2001 107 4 431 8 10.1172/JCI11526 11181642
8. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. G Pollakis S Kang A Kliphuis MI Chalaby J Goudsmit WA Paxton, J Biol Chem 2001 276 16 13433 41 10.1074/jbc.M009779200 11278567
9. A new perspective on V3 phenotype prediction. S Pillai B Good D Richman J Corbeil, AIDS Res Hum Retroviruses 2003 19 2 145 9 10.1089/088922203762688658 12643277
10. Predicting HIV-1 coreceptor usage with sequence analysis. MA Jensen AB van 't Wout, AIDS Rev 2003 5 2 104 12 12876899
11. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates. AJ Low W Dong D Chan T Sing R Swanstrom M Jensen S Pillai B Good PR Harrigan, AIDS 2007 21 14 17 24 10.1097/QAD. 0b013e3282ef81ea 17721088
12. Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection. SS Lieberman-Blum HB Fung JC Bandres, Clin Ther 2008 30 7 1228 50 10.1016/S0149-2918(08)80048-3 18691983
13. Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, China. JQ Xu JJ Wang LF Han C Xu YH Ruan ZH Xu X Chen ZD Liu J Wang B Su XP Ding B Gao YB Gu XY Cao H Xing KX Hong H Peng QB Zhao L Yuan Y Feng GY Zhang LY Ma L Wu YM Shao, Chin Med J (Engl) 2006 119 23 1941 8 17199937
14. Sequence analysis of gag and env genes of HIV type 1 circulating in former blood donors of Fuyang city, Anhui province. WS-hXHW Jian-jun, National medical journal of china 2007 87 22
15. HIV-1 infection in commercial plasma donors in China. Z Wu Z Liu R Detels, Lancet 1995 346 8966 61 2 10.1016/S0140-6736(95)92698-4 7603178
16. The HIV epidemic in China: history, response, and challenge. N He R Detels, Cell Res 2005 15 11-12 825 32 10.1038/sj.cr.7290354 16354555
17. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. PW Hunt PR Harrigan W Huang M Bates DW Williamson JM McCune RW Price SS Spudich H Lampiris R Hoh T Leigler JN Martin SG Deeks, J Infect Dis 2006 194 7 926 30 10.1086/507312 16960780
18. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes. C Garrido V Roulet N Chueca E Poveda A Aguilera K Skrabal N Zahonero S Carlos F Garcia JL Faudon V Soriano C de Mendoza, J Clin Microbiol 2008 46 3 887 91 10.1128/JCM.01611-07 18199789
19. Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07-BC strains circulating in the Xinjiang Province of China. L Ma Y Guo L Yuan Y Huang J Sun S Qu X Yu Z Meng X He S Jiang Y Shao, Retrovirology 2009 6 45 10.1186/1742-4690-6-45 19442296
20. Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell assay. D Vodros C Tscherning-Casper L Navea D Schols E De Clercq EM Fenyo, Virology 2001 291 1 1 11 10.1006/viro.2001.1163 11878871
21. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. S Kumar M Nei J Dudley K Tamura, Brief Bioinform 2008 9 4 299 306 10.1093/bib/bbn017 18417537
22. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. MA Jensen FS Li AB van 't Wout DC Nickle D Shriner HX He S McLaughlin R Shankarappa JB Margolick JI Mullins, J Virol 2003 77 24 13376 88 10.1128/JVI.77.24.13376-13388.2003 14645592
23. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. T Sing AJ Low N Beerenwinkel O Sander PK Cheung FS Domingues J Buch M Daumer R Kaiser T Lengauer PR Harrigan, Antivir Ther 2007 12 7 1097 106 18018768